{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-039143","form_type":"8-K","ticker":"TRUG","cik":"0001857086","company_name":"TruGolf Holdings, Inc.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.137881+00:00","generated_at":"2026-06-09T00:58:38.775102+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Deep Medicine Acquisition Corp. enters into up to $8M convertible note PIPE financing for TruGolf deal","bullets":["Up to $8M in convertible notes with 10% OID across three tranches; $2.11M funded at close of Business Combination.","Convertible at lower of $10/share or 10-day VWAP with $5 floor; interest at 10% (15% if paid in stock).","Warrants to purchase 727,273 shares at $13 exercise price, exercisable for 5 years.","Financing contingent on closing of Business Combination between DMAQ and TruGolf; subject to stockholder approval.","Registration rights agreement requires filing within 30 days of closing; liquidated damages of 2%/month for delays."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-039143","json":"https://secwatch.observer/filing/0001493152-23-039143.json","markdown":"https://secwatch.observer/filing/0001493152-23-039143.md","text":"https://secwatch.observer/filing/0001493152-23-039143.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857086/000149315223039143/0001493152-23-039143-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857086/000149315223039143/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T00:58:38.775102+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5fde947e0d0f91bd64c9d243f18538f86be30d1f","claim":"TruGolf Holdings, Inc. entered into Loan Agreements with Greentree Financial Group, Inc. and Finuvia, LLC valued at up to $8,000,000 in principal amount of convertible notes (effective 2023-11-02).","evidence_excerpt":"On November 2, 2023, Deep Medicine Acquisition Corp., a Delaware corporation (“ DMAQ ” or the “ Company ”), executed a Loan Agreement (together, the “ Loan Agreements ”) with each of Greentree Financial Group, Inc. and Finuvia, LLC (together, the “ PIPE Investors ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1857086/000149315223039143/0001493152-23-039143-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Greentree Financial Group, Inc. and Finuvia, LLC"},{"label":"Value","value":"up to $8,000,000 in principal amount of convertible notes"},{"label":"Effective","value":"2023-11-02"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}